-
AIDS Alert asked Mark Ishaug, president and chief executive officer of the newly-formed AIDS United of Washington, DC, to discuss why the National AIDS Fund and the national policy advocacy group AIDS Action merged and what this will mean for people living with HIV/AIDS and the clinicians providing their care. His answers are presented below in a question-and-answer (Q&A) format.
-
On Dec. 22, 2010, the Food and Drug Administration approved a new 200 mg etravirine (Intelence®) tablet. Etravirine was originally approved in 2008, in only a 100 mg tablet formulation. The new 200 mg dosage form can help reduce pill burden for patients taking Intelence.
-
The National Newspaper Publishers Association (NNPA) has joined a cooperative effort using enhanced media coverage to re-engage African Americans in the fight against HIV/AIDS.
-
In this study, 2,499 hiv-seronegative men or transgender females who have sex with men (MSM) were randomized to daily TDF/FTC vs. placebo in a multicenter, controlled trial with clinical sites in North America, Latin America, Thailand, and Africa.
-
A prospective study from November 2001 through October 2005 in Israel collected nasopharyngeal wash specimens from children < 5 years who were diagnosed with community-acquired alveolar pneumonia.
-
Recurrent urinary tract infections (UTI) in females is a common and distressing clinical problem.
-
These authors examined the use of antimicrobials for skin and soft tissue infection (SSTI), comparing the presentation, complications, microbial results and outcomes of adults hospitalized at Denver Health Medical Center.
-
In this issue: Rivaroxaban may be dabigatran's first competitor; a new way to measure non-adherence to medication therapy; FDA Actions.
-
In 1854, london was rocked by a cholera epidemic that killed approximately 10,000 people. Using what are now considered classical epidemiological methods, Dr. John Snow traced the source of at least 500 of the infections to a single water pump at Broad Street, validating his theory that cholera was a water-borne disease 29 years before the etiologic agent was discovered by Robert Koch; removing the pump handle stopped the outbreak in that area.
-
I was asked earlier this week to see a patient with candidemia. The patient had severe cirrhosis and had previously had placement of a transjugular intrahepatic portosystemic shunt (TIPS) for control of complications of portal hypertension.
